James Loyd
Physician · Vanderbilt University Medical Center
Credentials: · ·
History
- 2019–Present
- 1976–1978
Pulmonary Disease
- 1973–1976
Internal Medicine
Research
American Journal of Respiratory and Critical Care Medicine · 2013 · 3,318 citations
Nature Genetics · 2000 · 1,157 citations
Telomerase mutations in families with idiopathic pulmonary fibrosis
New England Journal of Medicine · 2007 · Last of 13 authors · 1,065 citations
47 papers · 27 as a resident
42 papers
- JN
36 papers · 1 as a resident
30 papers
27 papers
- JK
24 papers · 1 as a fellow
21 papers
20 papers
Grants
- 2012–2023
Hormonal, Metabolic and Signaling Interactions in PAH
National Heart, Lung, and Blood Institute · P01
Contact PI · $19.2M · Vanderbilt University Medical Center
- 2010–2023
Mechanisms of Familial Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · P01
Project lead · $4M · Vanderbilt University Medical Center
- 2012–2017
Caveolar Defects Underlie the Genetic Origins of PAH
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.5M · Vanderbilt University Medical Center
- 2005–2012
IPF Clinical Trial Center at Vanderbilt
National Heart, Lung, and Blood Institute · U10
Contact PI · $974.4K · Vanderbilt University
Clinical trials
- 2012–2032
Hormonal, Metabolic, and Signaling Interactions in PAH
Principal investigator · Recruiting
Vanderbilt University Medical Center
- 2009–2014
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
Principal investigator · Completed · Phase 3
Duke University
- 2009–2011
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
Principal investigator · Terminated · Phase 3
Duke University
- 2007–2009
Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis
Principal investigator · Completed · Phase 3
Duke University